Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Neuronetics, Inc. - Common Stock (NQ:STIM)

1.490 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Nov 19, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 1.490
Bid (Size) 1.500 (1,100)
Ask (Size) 1.530 (900)
Prev. Close 1.490
Today's Range 1.490 - 1.490
52wk Range 0.6750 - 5.920
Shares Outstanding 66,113,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Top 3 Health Care Stocks Which Could Rescue Your Portfolio In November ↗
 
Via Benzinga
News headline image
TRICARE West Expands NeuroStar® TMS Coverage to Include Adolescents Aged 15+ Struggling with Depression
New Policy Update Brings Innovative, Non-Drug Depression Treatment to Adolescents Across 26 States 
From Neuronetics
Via GlobeNewswire

Performance

YTD
N/A
N/A
1 Month
-45.4%
-45.4%
3 Month
-55.3%
-55.3%
6 Month
-62.8%
-62.8%
1 Year
+97.3%
+97.3%

More News

Read More
News headline image
Tuesday's pre-market session: top gainers and losers ↗
Via Chartmill
News headline image
Earnings Scheduled For November 4, 2025 ↗
Via Benzinga
News headline image
Earnings Scheduled For August 5, 2025 ↗
Via Benzinga
News headline image
Earnings Scheduled For May 6, 2025 ↗
Via Benzinga
News headline image
Earnings Scheduled For November 12, 2024 ↗
Via Benzinga
News headline image
NEURONETICS INC (NASDAQ:STIM) Stock Plummets 22% on Q3 2025 Revenue Miss ↗
Via Chartmill
News headline image
Neuronetics Announces Three-Year Exclusive Partnership with Elite DNA Behavioral Health to Expand NeuroStar Access and Operational Excellence
From Neuronetics
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
Via Benzinga
News headline image
New York State Medicaid Expands Coverage for TMS Therapy, Including NeuroStar® Advanced Therapy, to Treat Major Depressive Disorder (MDD)
From Neuronetics
Via GlobeNewswire
News headline image
Neuronetics Inc (NASDAQ:STIM) Reports Mixed Q2 2025 Earnings: Revenue Beat Overshadowed by Wider-Than-Expected Loss ↗
Via Chartmill
News headline image
NeuroStar Announces New Publication in JAACAP Open Highlighting Treatment Efficacy in Depressed Adolescents
From Neuronetics
Via GlobeNewswire
News headline image
Neuronetics Announces Clinical Presence at the 2025 Clinical TMS Society Annual Meeting and Progress in Greenbrook’s Personalized Care Trial Program
From Neuronetics
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
Via Benzinga
News headline image
Neuronetics Launches First Inaugural National TMS Therapy Awareness Day During Mental Health Awareness Month
From Neuronetics
Via GlobeNewswire
News headline image
Evernorth Health Services, a Cigna Company, Expands NeuroStar® TMS Coverage for Adolescents Struggling with Depression
From Neuronetics
Via GlobeNewswire
News headline image
What's going on in today's pre-market session ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
Via Benzinga
News headline image
Earnings Scheduled For March 4, 2025 ↗
Via Benzinga
News headline image
These stocks are moving in today's after hours session ↗
Via Chartmill
News headline image
NeuroStar Unveils Two Significant Publications on TMS Therapy for Depression
From Neuronetics
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
Via Benzinga
News headline image
NeuroStar® Oral Presentation at AACAP 2024 Highlights Largest Study Evaluating TMS Efficacy in Adolescents with Depression
From Neuronetics
Via GlobeNewswire
News headline image
Health Care Service Corporation Adds First-Line TMS Coverage for Adolescents
From Neuronetics
Via GlobeNewswire

Frequently Asked Questions

Is Neuronetics, Inc. - Common Stock publicly traded?
Yes, Neuronetics, Inc. - Common Stock is publicly traded.
What exchange does Neuronetics, Inc. - Common Stock trade on?
Neuronetics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Neuronetics, Inc. - Common Stock?
The ticker symbol for Neuronetics, Inc. - Common Stock is STIM on the Nasdaq Stock Market
What is the current price of Neuronetics, Inc. - Common Stock?
The current price of Neuronetics, Inc. - Common Stock is 1.490
When was Neuronetics, Inc. - Common Stock last traded?
The last trade of Neuronetics, Inc. - Common Stock was at 11/19/25 04:00 PM ET
What is the market capitalization of Neuronetics, Inc. - Common Stock?
The market capitalization of Neuronetics, Inc. - Common Stock is 98.51M
How many shares of Neuronetics, Inc. - Common Stock are outstanding?
Neuronetics, Inc. - Common Stock has 99M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.